Cardiology Division, Fondazione Toscana Gabriele Monasterio, Italy.
Insitute of Life Sciences, Scuola Superiore Sant'Anna, Italy.
Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. doi: 10.1177/2047487320924501. Epub 2020 May 11.
Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.
患有心血管危险因素或已患有心血管疾病的患者罹患 19 型冠状病毒病的风险增加，感染后预后更差，但将这一概念转化为有效行动具有挑战性。目前尚不清楚心血管治疗是否可以降低感染的可能性，或者提高感染患者的生存率。鉴于这一问题对临床心脏病专家和所有处理 19 型冠状病毒病的专家至关重要，我们试图总结当前的证据并提供一些实用建议。
